Multicenter evaluation of analytical performance of the Liaison® troponin I assay

被引:16
作者
Pagani, F
Stefini, F
Chapelle, JP
Lefèvre, G
Graïne, H
Luthe, H
Engelmayer, J
Panteghini, M
机构
[1] Spedali Civil Brescia, Lab Anal Chim Clin 1, I-25125 Brescia, Italy
[2] Liege Univ Hosp, Dept Clin Chem, Liege, Belgium
[3] Hop Tenon, Serv Biochim & Hormonol, Paris, France
[4] Univ Gottingen, Dept Clin Chem, Gottingen, Germany
关键词
troponin I; immunoassay; myocardial infarction; reference values;
D O I
10.1016/j.clinbiochem.2004.04.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: This study evaluated the analytical characteristics of the Liaison(R) immunoassay for cardiac troponin I (cTnI). Design and methods: The protocol consisted of eight sections: evaluation of antibody specificity, linearity, detection limit and imprecision, method comparison, evaluation of endogenous interferents, anticoagulant interference, sample stability, and reference values. Results: The assay equally measured free and complexed cTnI. The minimum detectable cTnI concentration was 0.021 mug/l. The cTnI concentration corresponding to a total CVof 10% was 0.056 mug/l. Linearity of response was demonstrated along the entire dynamic range of the assay. Assay interferences were minimal. cTnI concentrations in serum and heparinized plasma were significantly different. Values in EDTA plasma were on average approximately 5% higher than in matched serum, but this difference was not significant. The 99th percentile cTnI value in healthy subjects was 0.036 mug/l. Conclusions: Being sensitive, specific, and precise, the Liaison(R) cTnI assay meets current requirements to aid in the diagnosis of myocardial necrosis. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 24 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials [J].
Apple, FS ;
Wu, AHB ;
Jaffe, AS .
AMERICAN HEART JOURNAL, 2002, 144 (06) :981-986
[3]  
Apple FS, 2001, CLIN CHEM, V47, P377
[4]  
Baum H, 2002, CLIN CHEM, V48, pA83
[5]  
BURNETT RW, 1980, CLIN CHEM, V26, P644
[6]  
Dorizzi RM, 2002, CLIN CHEM, V48, pA90
[7]   Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction [J].
Ferguson, JL ;
Beckett, GJ ;
Stoddart, M ;
Walker, SW ;
Fox, KAA .
HEART, 2002, 88 (04) :343-347
[8]  
Gerhardt W, 2000, CLIN CHEM, V46, P817
[9]  
Ismail AAA, 2002, CLIN CHEM, V48, P2023
[10]   It's time for a change to a troponin standard [J].
Jaffe, AS ;
Ravkilde, J ;
Roberts, R ;
Naslund, U ;
Apple, FS ;
Galvani, M ;
Katus, H .
CIRCULATION, 2000, 102 (11) :1216-1220